Pay in 4 interest-free payments of $6.29 Learn more
Ships within 48 hours · Estimated delivery Sep 7 - Sep 12
the first ever generic GLP-1 product specifically indicated for weight loss," said Ernie Richardsen, SVP, Head of U.S
Cazzola M, et al
Well provide clear instructions on how to get in touch for follow-up questions, medication support, or dose adjustments
Evidence suggesting possible risk: rodent studies showed clear tumors GLP-1 receptors exist in human thyroid tissue GLP-1 drugs may influence calcitonin production isolated human case reports exist Evidence suggesting lower risk: humans have fewer GLP-1 receptors in thyroid tissue clinical trials did not show a statistically significant increase most cases are anecdotal or isolated The FDAs position: The risk cannot be ruled out
Cardiovascular Protection GLP-1 receptor agonists are also known to reduce the risk of cardiovascular events, such as heart attacks and strokes, which are prevalent among older adults
